Scroll To Top
Search by Speciality

12th Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease

Hilton Hotel Universal City * | Los angeles, USA
From 150 to 625 USD
Event Preview
EXPIRED
This event
is Finished
Title: 12th Annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease
Specialty: , Cardiology
Dates: From Nov, 20, 2014 to Nov, 22, 2014
Location: Los angeles, USA
Type: Congress
Registration Cost: From 150 to 625 USD
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Nov
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for Los Angeles, Usa.
General Info
Event Venue:

Hilton Hotel Universal City *

Los Angeles, USA Visit the Venue to read more
Currency:
USD
Event Overview
Welcome message:

The World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC), now in its 12th year, is a unique and exciting multidisciplinary program, to be held this year at the Hilton Hotel in  Universal City, California. The Congress is the premiere global meeting dedicated to obesity, diabetes, metabolism, and energy balance, linking research to clinical practice, and highlighting our theme — exploring new frontiers in metabolism —tomorrow's clinical science today.

 

Since its inception, the Congress has become a home to clinical & basic scientists, researchers, and practicing clinicians. The distinguished global faculty, employing the Congress’ unique bench-to-bedside approach, has developed a state-of-the-art program, promoting a new understanding of metabolic diseases; facilitate the development of future therapeutic modalities; and implement the management of obesity and diabetes with contemporary medications.

 

Since Dr. Gerald Reaven’s pioneering work crystallized the relationship between insulin resistance and diabetes & cardiovascular disease (CVD), the Congress’ focus has been augmented by the role of obesity, fat cell, and inflammation, in furthering cardiometabolic disease. The WCIRDC has become a distinguished platform where the interaction of multiple metabolic systems, like circadian rhythm, sleep disturbances, the neuroendocrine system, the gut, and related hormones, and their relationship to the brain, are evaluated in both the scientific and clinical environments. Ultimately the Congress is set on developing an innovative and comprehensive plan for managing CV risk factors and diseases.

 

This year will focus on the scientific basis for congestive heart failure (CHF), peripheral vascular disease (PVD), and thrombosis; and new therapeutic modalities to allow clinical management of these conditions.

 

For the clinicians, the Congress will feature a series of workshops and “meet the expert” panels, on the clinical management of diabetes, obesity, lipids, and hypertension. To make basic and clinical research topics like metabolism, vascular biology, fat cell, inflammation, immunology, and the endothelium relevant to clinical medicine, there will be a clinical implications commentary, and panel discussions by recognized clinical experts, following these sessions.

 

Congress abstracts will be published in Endocrine Practice, the official journal of the American Association of Clinical Endocrinologists (AACE). Articles about the meeting will also be published, both in Endocrine Practice and in other medical journals.

Speakers/Faculty:

 
Yehuda Handelsman MD FACP, FACE, FNLA

Medical Director Principal investigator

Metabolic Institute of America

Chair, ICIR

Tarzana, California

 


Zachary T. Bloomgarden, MD

Clinical Professor of Medicine

Mount Sinai School of Medicine

Assistant Attending in Medicine

Mount Sinai Hospital

Consultant in Endocrinology

Lawrence Hospital

New York, New York

 

Nathan M. Bass, MBChB, PhD, FACP (MD)

Professor of Medicine Emeritus ,

University of San Francisco , CA

 

David S. Boyer, MD

Clinical Professor of Ophthalmology

University of Southern California

Keck School of Medicine

Senior Partner

Retina Vitreous Associated Medical Group

Los Angeles, California

 


Sonia Caprio, MD

Professor of Pediatric Endocrinology

Yale University School of Medicine

New Haven, Connecticut

 


Robert J. Chilton, DO, FACC

Professor of Medicine

Department of Medicine

Division of Cardiology

The University of Texas

Health Science Center

San Antonio, Texas

 


Rhoda H. Cobin, MD, MACE

Clinical Professor of Medicine

Mount Sinai School of Medicine

Past President ,AACE & ACE

New York, New York

 


Jaime A. Davidson, MD, FACP, MACE

Clinical Professor of Medicine

Division of Endocrinology

Diabetes and Metabolism 

Touchstone Diabetes Research Center

The University of Texas

Southwestern Medical Center

Dallas, Texas

 

Michael H. Davidson, MD

Clinical Professor

Director of the Lipid Clinic

The University of Chicago

Pritzker School of Medicine

Chicago, IL

 

Ralph A. DeFronzo, MD

Professor of Medicine

Chief, Diabetes Division

University of Texas

Health Science Center

Deputy Director

Texas Diabetes Institute

San Antonio, Texas

 

Andrew J. Drexler, M.D.

Professor of Medicine

Co-Chief, Division of Clinical Endocrinology,

Diabetes and Hypertension

Director, Gonda (Goldschmied) Diabetes Center

Los Angeles, California

 


Daniel Einhorn, MD, FACP, FACE

Clinical Professor of Medicine

Diabetes and Endocrine Associates

Medical Director, Scripps Whittier

Institute for Diabetes

San Diego, California

 

Ronald M. Evans, PhD

Professor, The Salk Institute

Investigator, Howard Hughes Medical Institute

March of Dimes Chair in Molecular

and Developmental Biology

San Diego, California

 

Ariel E. Feldstein, MD

Professor of  Pediatrics

Chief, Division of pediatrics, Gastroenterology

Hepatology and Nutrition

University of California, San Diego, California

 

Alan J. Garber, MD, PhD, FACE

Professor

Departments of Medicine,

Biochemistry & Molecular Biology

and Molecular and Cellular Biology

Baylor College of Medicine

Department of Medicine

Division of Diabetes, Endocrinology and Metabolism

Houston, Texas

 

George Grunberger, MD, FACP, FACE

Chairman, Grunberger Diabetes Institute,

Clinical Professor, Department of Internal Medicine

and Center for Molecular Medicine & Genetics,

Wayne State University School of Medicine, Detroit, MI

Bloomfield Hills, MI

Professor, Department of Medicine,

Oakland University William Beaumont

School of Medicine

Rochester, MI

 


W. Timothy Garvey, MD

Butterworth Professor and Chair

Department of Nutrition Sciences

GRECC Investigator and staff physician

Birmingham VA Medical Center

Director, UAB Diabetes Research and Training Center

Birmingham, Alabama

 

Phillip Gorden, M.D.

Director Emeritus & Senior Investigator

National Institutes of Diabetes

Digestive and Kidney Disease

National Institutes of Health

Bethesda, Maryland

 


Peter J. Grant, MD, FMedSci

Professor of Medicine and Consultant Physician

Leeds Acute Trust, LIGHT Laboratories,

University of Leeds

Leeds, United Kingdom

 


Paul S. Jellinger, MD, MACE

Clinical Professor of Medicine,

Voluntary Faculty

University of Miami

The Center for Diabetes &

Endocrine Care

Past President, AACE & ACE

Hollywood, Florida

 

Ishwarlal (Kenny) Jialal, MD, PhD

Professor of Medicine

Division of Endocrinology, Diabetes and Metabolism

Robert E. Stowell Endowed Chair in Experimental Pathology

Director of the Laboratory for Atherosclerosis and Metabolic Research,

Director, Special Chemistry and Toxicology.

UC Davis, CA

 


Samuel Klein, MD

Professor of Medicine & 

Nutritional Science William H. Danforth 

Director, Center for Human Nutrition

Chief, Division of Geriatrics &

Nutritional Science

Washington University

School of Medicine

St Louis, Missouri

 


Philip Levy, MD, MACE

Clinical Professor of Medicine

University of Arizona College of Medicine

Phoenix Endocrinology Clinics, Ltd.

Past President ACE

Phoenix, Arizona

 

Gary F. Lewis, MD

Professor, Departments of Medicine & Physiology

Director, Banting and Best Diabetes Center

Director, Division of Endocrinology & Metabolism

University of Toronto

Toronto, On, Canada

 


Ronald M. Krauss, MD

Director, Atherosclerosis Research Children’s Hospital Oakland

Senior Scientist, Genome Sciences Division Lawrence Berkeley

National Laboratory University of California

Berkeley, California

 

Clifford J. Rosen MD

Professor of Medicine,

Tufts University School of Medicine

Director of Clinical and Translational Research,

Maine Medical Center Research Institute

Boston Massachusetts

 


Alan R. Sinaiko, MD

Professor, Department of Pediatrics

Division of Nephrology

University of Minnesota

Medical School Pediatric Nephrology

Minneapolis, Minnesota

 

Alan S. Maisel, MD

Professor of Medicine

Director Coronary Care Unit and Heart Failure program

Veterans Affairs San Diego Healthcare System

San Diego, California

 


Nikolaus Marx, MD, FAHA

Professor of Medicine / Cardiology

Head of the Department of Internal Medicine

University Hospital Aachen

Aachen, Germany

 

Darren K. McGuire, MD, MHSc, FAHA, FACC

Professor of Internal Medicine

Dallas Heart Ball Chair For

Research on Heart Disease in Woman

University of Texas Southwestern Medical Center

Dallas, Texas

 


Tracey L. McLaughlin, MD, MS

Assistant Professor of Medicine

Division of Endocrinology,

Gerontology and Metabolism

Stanford Medical Center

Stanford, California

 

Marc R. Montminy, MD PhD 

Professor of Medicine

Clayton Foundation Laboratories for Peptide Biology 

J.W. Kieckhefer Foundation Chair

The Salk Institute for Biological Studies

La Jolla, California 

 

NING Guang, MD, Ph.D. 

Professor of medicine

Principal Investigator

Laboratory of Endocrine & Metabolic Diseases

The Institute of Health Sciences

Shanghai, China

 

Walter J. Pories, MD, FACS

Professor of Surgery, Biochemistry

Exercise and Sport Science

Director, Bariatric Surgery Research 

Division of Advanced Laparoscopic,

Gastrointestinal and Endocrine Surgery

Brody School of Medicine

East Carolina University

Greenville, North Carolina

 

Michael W. Schwartz, MD

Robert H. Williams Endowed Chair in Medicine

Director, Diabetes and Obesity Centerof Excellence

Director, UW Nutrition Obesity Research Center

Professor of Medicine, Division of Metabolism, Endocrinology and Nutrition

University of Washington

 

Reuben J. Shaw, PhD

Associate Professor

Howard Hughes Medical Institute

Molecular and Cell Biology Laboratory

The Salk Institute for Biological Studies

La Jolla, Califronia 

 


Bart Staels, PhD  

Full Professor, University of Lille

Nord de France

Head of Inserm

Lille, France

 

Gerald M. Reaven, MD

Professor of Medicine (Active Emeritus)

Division of Cardiovascular Medicine

Stanford University

School of Medicine

Stanford, California

 


Jorge Plutzky, MD

Director, The Vascular Disease

Prevention Program Cardiovascular Division

Brigham and Women's Hospital

Harvard Medical School

Boston, Masachusetts

 

Paul D. Rosenblit, MD , PhD FACE, FNLA

Clinical Professor of Medicine

Division of Endocrinology Diabetes & Metabolism

University of California-Irvine School of Medicine

Co Director Diabetes

Out Patient Clinic Director

Diabetes Lipid Management & Research Center

Irvine, California

 

Allan Sniderman, MD

Professor of Medicine

McGill University.

Director of the Mike Rosenbloom Laboratory for

Cardiovascular Research

Royal Victoria Hospital in

Montreal, Canada

 



John E. Gerich, MD

Professor Emeritus-University of Rochester

School of Medicine

Rochester, New York
Registration Not yet available Register Now
Accommodation
Accommodation:

The 12th Annual World Congress on Insulin Resistance, Diabetes & CVD (WCIRDC) will be held at the prestigious Sheraton Universal Hotel.The majestic Sheraton Hotel is situated on a hill high above the Los Angeles Entertainment District, at the very entrance to Universal Studios Hollywood and CityWalk. Every room of the hotel offers commanding views of the Hollywood Hills, San Fernando Valley, and Universal Studios Hollywood. The hotel is six miles from the Burbank Airport, and 30 minutes from the Los Angeles International Airport.  

 

Hilton Universal City Hotel

 

555 Universal Hollywood Dr.  

Universal City  CA   91608

 

Make reservations HERE 

or call (818) 980-1212 and reference the group name "WCIRDC"

To receive the special group rate of $169/night for conference participants and their guests. Rooms will be available on a first-come basis, and will be available until all are filled. Group room rates will be available three (3) days prior to and three (3) days after the event dates. If you need special accommodations or if you have any questions about access to any of our activities, please contact the meeting organizers at: (818)-342-1889 or info@wcir.org.

 

Scientific Content Up to Date
Submission Info

WCIRDC 2014

11/20/14-11/22/14

Hilton Hotel-Universal City,  CA

Deadline for Submission: October 13, 2014

 

Abstract Submission & Topics:


Clinical aspects of insulin resistance in childhood, adolescence
and/or adulthood pertaining to:

Diabetes, obesity, dyslipidemia, hypertension, cardiovascular disease, malignancy, liver disease, renal disease, gonadal dysfunction, sleep disorders such as obstructive sleep apnea

Basic science:
Mechanisms of insulin resistance, inflammation, endothelial and vascular dysfunction, metabolic dysfunction of centers such as the beta cell, adipocyte, gut, and brain

 

 

Guidelines:

Abstracts should address either clinical or basic science aspects of insulin resistance, in fields such as diabetes, obesity, and cardiovascular disease.  Investigations of overall pathophysiology and/or effects on key metabolic centers such as the beta cell, adipocyte, gut, and brain would be of interest, as would be studies of inflammation and of endothelial or other vascular dysfunction. Clinical topics may include any aspect of insulin resistance in childhood, adolescence and/or adulthood in relationship to the causation and/or natural history of obesity, diabetes, hypertension, dyslipidemia, cardiovascular disease, renal disease, gonadal dysfunction (including both PCOS and male hypogonadism), gestational diabetes, other endocrine abnormality, liver disease (NAFLD), malignancy, and sleep disorders such as obstructive sleep apnea.   

The interests of the Congress include multi-hormonal aspects of obesity, incretins and other gut hormonal contributions to energy balance, and circadian rhythm as it relates to these metabolic mechanisms. Basic science studies should include those with specific relationship to insulin action and its regulation at the cellular, organ, or whole body level.

 

To demonstrate their conformity to this guideline, authors are encouraged to include a brief clarification of the relationship of their topic to insulin resistance and/or to the above metabolic processes.

 

In addition:

  • Scientific materials presented at the 12th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease must not have been published or presented prior to November 20, 2014, other than in abstract form.
  • All abstracts must be filed electronically and emailed to us (info@wcir.org ), as a Microsoft Word document of no more than 250 words saved as .RTF (Rich Text Format). Submissions will not be accepted by fax or mail.  
  • All materials must arrive on or before the abstract deadline noted above.
  • Notification for acceptance will be e-mailed as soon as the committee accepts the abstract.   
  • Authorship on multiple abstracts is permitted.
  • All submitted materials will be graded by the scientific planning committee, The International Committee for Insulin Resistance.
  • Abstracts may be submitted for poster presentation. If selected for poster presentation, the author is required to register for the Congress and to be present during the poster sessions. Awards will be given for the highest-ranking abstracts. The award levels are: Gold, Silver, Bronze, and honorable mention. The authors of the winning abstracts will orally present their research findings during the Plenary Sessions in a ten minute presentation, to be followed by a five minute period of discussion.
  • If selected for oral presentation, an author is required to register for the Congress and to be prepared for the oral presentation with a PowerPoint presentation.  Abstracts must be accompanied by a statement from the authors agreeing that, if chosen, they will prepare a poster presentation, and that, if awarded a high ranking, they will prepare an oral presentation.
  • Abstracts will be published in: Endocrine Practice.
    Editor-in-Chief – Dr. Lewis E. Braverman
    “Endocrine Practice is a peer-reviewed journal published six times a year, and is the official journal of the American College of Endocrinology (ACE) and the American Association of Clinical Endocrinologists (AACE). The first issue of Endocrine Practice was published in 1995. The primary mission of Endocrine Practice is to enhance the health care of patients with endocrine diseases through continuing education of practicing endocrinologists.”                    


Abstract Committee:

Zachary Bloomgarden, MD, Chair 
Clinical Professor of  Medicine  
Mount Sinai  School of Medicine
 
Phillip Levy, MD, FACE
Clinical Professor of  Medicine
University of  Arizona  College of Medicine
 
Daniel Einhorn, MD, FACE, FACP
Clinical Professor of Medicine
Diabetes and Endocrine Associates
Medical Director, Scripps Whittier
Institute for Diabetes

 

Late Breaking Abstracts Accepted:

  • Will be published in Endocrine Practice, the official journal of AACE.
  • Will be considered for poster presentation in the meeting.
  • In some cases, the committee may consider Late Breaking Abstracts for oral presentation.

 

Travel Grant Announcement:


For eligible young international physicians or researchers, 2014 Poster Session participants

 

General Information
The WCIRDC is pleased to offer a travel grant program for international physicians who are practicing outside of the United States of America (USA). The goal of this program is to provide financial support in the form of travel grants (up to $500) to international physicians so they will have an opportunity to present a poster at the 2014 Annual Meeting in Los Angeles, California, on November 20, 2014-November 22, 2014

There will be 3 total grants awarded. Each grant award is based on a general criteria.

 

Criteria

  • Applicant must be younger than 35 years of age.
  • Applicant is presenting a poster at the 2014 Annual Meeting Poster Session, and has not have presented prior to November 20, 2014
    • Past WCIRDC “Travel Grant” award recipients are not allowed to apply again.
  • Participation will have a positive effect on the applicant's career.
  • Abstract (poster) will have a significant impact on the WCIRDC Annual Meeting.

 

Session's Content
Award Recipients of the International Travel Grant for Physicians will receive an amount, to be determined, for travel expenses (up to $500). The awardees will be notified in writing via e-mail or fax. 

Sponsors Exhibitors
Contact
Organising Agency
Metabolic Endocrine Education Foundation
18372 Clark Street Suite 212 Tarzana, CA 91356, United States
+1 818-342-1889
+1 818-342-1538

 

 
Official Event Webpage
Event map
Revelant Events